SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000891293-17-000075
Filing Date
2017-06-23
Accepted
2017-06-23 16:49:50
Documents
3
Effectiveness Date
2017-06-23

Document Format Files

Seq Description Document Type Size
1 S-8 cti-formsx8forinducementop.htm S-8 96143
2 EXHIBIT 5.1 exhibit_5x1xopinionxstockx.htm EX-5.1 14096
3 EXHIBIT 24.1 forms-8forinducementoption.htm EX-24.1 3917
  Complete submission text file 0000891293-17-000075.txt   115255
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218946 | Film No.: 17928194
SIC: 2834 Pharmaceutical Preparations